Skip to main content

Advertisement

SpringerLink
Log in

Geographical, gender and age inequalities in non-communicable diseases both at national and provincial levels in Iran

  • Review article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Over 80% of deaths due to non-communicable diseases (NCDs) occur in low and middle-income countries, indicating an inequality in the health care system around the world. Conducted studies at provincial level in developed countries have shown that mortality rates due to this group of diseases are higher in the populations with lower education, income, and social class. NCDs account for 71.3% of total world deaths in 2016 and 79.2% of total deaths in Iran in the same year. Improving the health of Iranian population and reducing the number of communicable diseases over the past decades have made NCDs as a major health problem in Iran. In this study, we describe the status of most lethal NCDs in the country at national and provincial level. In addition, study on the inequality of deaths due to NCDs at provincial level in Iran showed that there is a considerable difference between different provinces. Furthermore, there is an age inequality so that mortality of main NCDs increased dramatically after the age of 70. Therefore, health policy makers and decision makers should adopt appropriate policies to reduce gender, geographic and age disparities to reduce gender and inter-provincial inequalities in Iran.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381(9866):585–97.

    Article  Google Scholar 

  2. Shadmani FK, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: a modeling study. PLoS One. 2019;14(2):e0211622.

    Article  Google Scholar 

  3. Khajavi A, Pishgar F, Dehghani M, Naderimagham S. Socioeconomic inequalities in neonatal and postneonatal mortality: evidence from rural Iran, 1998–2013. Int J Equity Health. 2017;16(1):83.

    Article  Google Scholar 

  4. Aminorroaya A, Fattahi N, Azadnajafabad S, Mohammadi E, Jamshidi K, Khalilabad MR, et al. Burden of non-communicable diseases in Iran: past, present, and future. J Diabetes Metab Disord. 2020:1–7. https://doi.org/10.1007/s40200-020-00709-8.

  5. The National and Subnational Burden of Diseases. Injuries, and Risk Factors (NASBOD). Tehran: NCDRC, Tehran University of Medical Sciences; 2015. [cited 12 14 2019]. Available from: https://vizit.report/en/dashboard.html

    Google Scholar 

  6. Modirian M, Rahimzadeh S, Cheraghi Z, SAEEDI MS, Rezaei N, Tohidinik HR, et al. Burden of cancers in Iran from 1990 to 2010: findings from the global burden of disease study 2010. 2015.

    Google Scholar 

  7. Fereshtehnejad SM, Vosoughi K, Heydarpour P, Sepanlou SG, Farzadfar F, Tehrani-Banihashemi A, et al. Burden of neurodegenerative diseases in the eastern Mediterranean region, 1990–2016: findings from the global burden of disease study 2016. Eur J Neurol. 2019;26(10):1252–65.

    Article  Google Scholar 

  8. Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(12):1083–97.

    Article  Google Scholar 

  9. Varmaghani M, Dehghani M, Heidari E, Sharifi F, Moghaddam SS, Farzadfar F. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57.

    Article  Google Scholar 

  10. Djalalinia S, Peykari N, Qorbani M, Larijani B, Farzadfar F. Inequality of obesity and socioeconomic factors in Iran: a systematic review and meta-analyses. Med J Islam Repub Iran. 2015;29:241.

    PubMed  PubMed Central  Google Scholar 

  11. Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3.

    Article  Google Scholar 

  12. Gohari K, Rezaei N, Farshad Farzadfar M. National and subnational patterns of cause of death in Iran 1990-2015: applied methods. Arch Iran Med. 2017;20(1):2.

    PubMed  Google Scholar 

  13. Peykari N, Hashemi H, Asghari G, Ayazi M, Janbabaei G, Malekzadeh R, et al. Scientometric study on non-communicable diseases in Iran: a review article. Iran J Public Health. 2018;47(7):936–43.

    PubMed  PubMed Central  Google Scholar 

  14. Mohammadi Y, Parsaeian M, Farzadfar F, Kasaeian A, Mehdipour P, Sheidaei A, et al. Levels and trends of child and adult mortality rates in the Islamic Republic of Iran, 1990–2013; protocol of the NASBOD study. 2014.

    Google Scholar 

  15. Global Burden of Disease Study (GBD). University of Washington. [cited 12 14 2019]. 2017

  16. Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A, et al. NASBOD 2013: Design, definitions, and metrics (study protocol). 2014.

    Google Scholar 

  17. Gholami A, Baradaran HR, Khatibzadeh S, Sheidaei A, Parsaeian M, Farzadfar F. National and subnational cardiovascular diseases mortality attributable to salt consumption in Iran by sex and age from 1990 to 2016. Arch Iran Med. 2018;21(3):122–30.

    PubMed  Google Scholar 

  18. Maracy MR, Isfahani MT, Kelishadi R, Ghasemian A, Sharifi F, Shabani R, et al. Burden of ischemic heart diseases in Iran, 1990-2010: findings from the global burden of disease study 2010. J Res Med Sci. 2015;20(11):1077–83.

    Article  CAS  Google Scholar 

  19. Larijani FA, Parsaeian M, Motamedi SMK, Khosravi A, Farzadfar F, Larijani B. National trends in mortality attributable to metabolic risk factors in Iran. Lancet. 2013;381:S79.

    Article  Google Scholar 

  20. Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, et al. Cardiovascular mortality in a Western Asian country: results from the Iran cohort consortium. BMJ Open. 2018;8(7):e020303.

    Article  Google Scholar 

  21. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.

    Article  Google Scholar 

  22. Salimzadeh H, Delavari F, Sauvaget C, Rezaee N, Delavari A, Kompani F, et al. Annual trends of gastrointestinal cancers mortality in Iran during 1990-2015; NASBOD study. Arch Iran Med. 2018;21(2):46–55.

    PubMed  Google Scholar 

  23. Modirian M, Rahimzadeh S, Cheraghi Z, Khosravi A, Salimzadeh H, Kompani F, et al. Quality evaluation of national cancer registry system in Iran: study protocol. 2014.

    Google Scholar 

  24. Rezaei N, Pishgar F, Yoosefi M, Sheidaei A, Moghaddam SS, Mansouri A, et al. National and Sub-National Pediatric Cancer Mortality in Iran, 2000–2015. Arch Iranian Med. 2019;22(6):293–300.

    Google Scholar 

  25. Pishgar F, Haj-Mirzaian A, Ebrahimi H, Saeedi Moghaddam S, Mohajer B, Nowroozi MR, et al. Global, regional and national burden of testicular cancer, 1990–2016: results from the global burden of disease study 2016. BJU Int. 2019;124:386–94.

    Article  Google Scholar 

  26. Mohammadi E, Aminorroaya A, Fattahi N, Azadnajafabad S, Rezaei N, Farzi Y, et al. Epidemiologic pattern of cancers in Iran; current knowledge and future perspective. J Diabetes Metab Disord. 2020:1–5. https://doi.org/10.1007/s40200-020-00654-6.

  27. Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, et al. Global, regional and National Burden of bladder Cancer, 1990 to 2016: results from the GBD study 2016. J Urol. 2019;201(5):893–901.

    Article  Google Scholar 

  28. Pishgar F, Amini E, Gohari K, Aminorroaya A, Sheidaei A, Rostamabadi Y, et al. National and subnational mortality of urological cancers in Iran, 1990–2015. Asia Pac J Clin Oncol. 2019;15(2):e43–e8.

    Article  Google Scholar 

  29. Naderimagham S, Alipour S, Djalalinia S, Kasaeian A, Noori A, Rahimzadeh S, et al. National and sub-national burden of breast cancer in Iran; 1990–2013. Arch Iranian Med. 2014;17(12):794–9.

    Google Scholar 

  30. Peykari N, Sepanlou SG, Djalalinia S, Kasaeian A, Parsaeian M, Ahmadvand A, et al. National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990-2013, study protocol. Arch Iran Med. 2014;17(1):54–61.

    PubMed  Google Scholar 

  31. Hassannia T, Delavari F. National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013; the study protocol. Arch Iran Med. 2014;17(12):800–3.

    PubMed  Google Scholar 

  32. Kelishadi R, Hovsepian S, Qorbani M, Jamshidi F, Fallah Z, Djalalinia S, et al. National and sub-national prevalence, trend, and burden of cardiometabolic risk factors in Iranian children and adolescents, 1990–2013 (study protocol). 2014.

    Google Scholar 

  33. Varmaghani M, Rashidian A, Kebriaeezadeh A, Moradi-Lakeh M, Moin M, Ghasemian A, et al. National and sub-national prevalence, trend, and burden of asthma in Iran from 1990 to 2013; the study protocol. Arch Iranian Med. 2014;17(12):804–9.

    Google Scholar 

  34. Varmaghani M, Farzadfar F, Sharifi F, Rashidain A, Moin M, MORADI LM, et al. Prevalence of asthma, COPD, and chronic bronchitis in Iran: a systematic review and meta-analysis. 2016.

    Google Scholar 

  35. Varmaghani M, Kebriaeezadeh A, Sharifi F, Sheidaei A, Rashidian A, Moradi-Lakeh M, et al. Death-specific rate due to asthma and chronic obstructive pulmonary disease in Iran. Clin Respir J. 2018;12(6):2075–83.

    Article  Google Scholar 

  36. Nichols E, Szoeke CE, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(1):88–106.

    Article  Google Scholar 

  37. Djalalinia S, Saeedi Moghaddam S, Rezaei N, Rezaei N, Mansouri A, Abdolhamidi E, et al. National and sub-national patterns of mortality from stroke in the Iranian population (1990–2015): Complementary results from the NASBOD study. Int J Stroke. 2018;15(2):132–48.

    Article  Google Scholar 

  38. Sharifi F, Najafi B, Fakhrzadeh H, Noroozian M, Naderimagham S, Philp I, et al. National and sub-national trend of prevalence and burden of dementia in Iran, from 1990 to 2013; study protocol. Arch Iranian Med. 2014;17(12):816–20.

    Google Scholar 

  39. Sahraian MA, Heydarpour P, Moradi-Lakeh M, Eskandarieh S, Fereshtehnejad SM, Vosughi K, et al. Burden of Multiple Sclerosis in Eastern Mediterranean Region (1990–2016): Findings From the 2016 Global Burden of Disease Study. medRxiv. 2019:19005918. https://doi.org/10.1101/19005918.

Download references

Availability of data and materials

All data is available through GBD VIZHUB and vizit. Report.

Author information

Authors and Affiliations

  1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Nima Fattahi, Sina Azadnajafabad, Esmaeil Mohammadi, Arya Aminorroaya, Shahabeddin Rezaei, Erfan Ghasemi, Negar Rezaei, Shohreh Naderimagham & Farshad Farzadfar

  2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Negar Rezaei, Shohreh Naderimagham, Bagher Larijani & Farshad Farzadfar

Authors
  1. Nima Fattahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sina Azadnajafabad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Esmaeil Mohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arya Aminorroaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shahabeddin Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Erfan Ghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Negar Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shohreh Naderimagham
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Farshad Farzadfar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have made a significant contribution to the manuscript and accept the responsibility for the study protocol and the presented results.

Corresponding authors

Correspondence to Shohreh Naderimagham or Bagher Larijani.

Ethics declarations

Conflict of interest

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fattahi, N., Azadnajafabad, S., Mohammadi, E. et al. Geographical, gender and age inequalities in non-communicable diseases both at national and provincial levels in Iran. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-020-00713-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40200-020-00713-y

Keywords

Search

Navigation